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Short Report 
Nostril widening improves arterial oxygenation: 
a role for nasal nitric oxide? 
M. HERULF”, J. 0. N. LUNDBERG” AND E. WEITZBERG+ 
“Department of Physiology and Pharmacology, Karolinska Institute and 
‘Department of Anaesthesiology and Intensive Care 171 76, iGolinska Hospital, Stockholm, Sweden ‘? 
Background 
Healthy humans normally breathe mostly through the nose, 
whereby the nasal cavity serves to regulate the temperature 
and humidity of the inhaled air. However, the nasal airways 
may not only function as an ingenious heat exchanger and 
humidifier; recently it was shown that the potent vasodila- 
tor nitric oxide (NO) is present in high concentrations in the 
nasal airways of healthy subjects (1). During nasal breath- 
ing substantially more NO reaches the lungs as compared 
to oral breathing and when inhaled this NO has been 
suggested to modulate pulmonary function (2,3). The 
anterior part of the nose is the narrowest passage in the 
upper airway and it accounts for more than half of the total 
airway resistance during nasal respiration (4). Therefore, 
nostril widening devices have been developed in order to 
improve nasal breathing. These include nasal tapes and 
were originally developed to be used by subjects suffering 
from snoring or sleep apnoea syndrome. Recently, these 
tapes have also been used by athletes in order to aid nasal 
breathing during physical exercise, although the beneficial 
effects of this concept have not been evaluated. 
Methods 
We studied the effects of nostril widening on arterial 
oxygenation in a group of 11 spontaneously breathing 
patients in a neurosurgical intensive care unit. The majority 
of the patients were unconscious and no instructions were 
given regarding breathing technique. All were in the supine 
position throughout the experiment and oxygen supplemen- 
tation was withdrawn 30 min before start. A nostril- 
widening tape (Breathe-right @, 3M Pharmaceuticals) was 
applied to the patients for 30 min. Arterial oxygenation 
(PaO,) was measured together with carbon dioxide 
(PaCO,) with a blood gas analyser at the end of this period 
and the values were compared to those obtained before the 
application and 30 min after the plaster had been removed. 
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FIG. 1. Effects of nostril widening on arterial oxygenation 
(PaO,) in spontaneously breathing patients. *P<O.O5 
compared to control; Student’s paired t-test. 
Results 
PaO, was higher during the period of nostril widening 
compared to before the treatment period whereas ventila- 
tion, as measured by PaCO,, remained unchanged through- 
out the experiment. Basal PaO, was 10.18 & 0.55 and rose 
to 10.81 * 0.42 (P~0.02). Thirty minutes after the plaster 
was removed, PaO,, had decreased to 10.41 * 0.57 (Fig. 1). 
Discussion 
Inhaled exogenous NO has been shown to improve oxy- 
genation and reduce pulmonary hypertension in patients 
with pulmonary disorders (5). The amounts of NO that 
reach the lung during nasal breathing (2) are in the same 
range as those proven to be effective during treatment with 
exogenous NO (5). A recent study shows that NO of nasal 
origin is involved in modulation of pulmonary function 
under normal as well as pathological conditions. Enhance- 
ment of nasal breathing with, for example, a nostril widener 
will lead to higher concentrations of NO in inspired air 
which may explain the results obtained in this study. This 
mechanism may add to the other well-known beneficial 
effects of nasal breathing. 
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